These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2123621)

  • 1. Current safety of clotting factor concentrates.
    Foster PR; McIntosh RV
    Arch Pathol Lab Med; 1990 Dec; 114(12):1188-9. PubMed ID: 2123621
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
    Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
    J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral safety and clotting factor concentrates.
    Laurian Y; Lusher JM; Kessler CM
    Thromb Haemost; 1994 Oct; 72(4):649. PubMed ID: 7878650
    [No Abstract]   [Full Text] [Related]  

  • 4. Current safety of clotting factor concentrates.
    Epstein JS; Fricke WA
    Arch Pathol Lab Med; 1990 Mar; 114(3):335-40. PubMed ID: 2407224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 6. Virus safety of pasteurized clotting factor concentrates.
    Kreuz W; Becker S; Auerswald G; Kurnick K; Kröniger A; Klarmann D
    Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():57-62. PubMed ID: 12016580
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood safety monitoring among persons with bleeding disorders--United States, May 1998-June 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 51(51-52):1152-4. PubMed ID: 12553567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of immune globulins.
    Tepper M; Gully P
    Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the risk of hepatitis from clotting factor concentrates.
    Fricke WA
    Prog Clin Biol Res; 1990; 324():161-6. PubMed ID: 2408051
    [No Abstract]   [Full Text] [Related]  

  • 13. Replacement therapy with virus-inactivated clotting factor concentrates in patients with severe hemophilia in Heidelberg.
    Zimmermann R; Uhle C; Huth-Kühne A
    Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():75-8. PubMed ID: 12016582
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk of infection caused by homologous blood transfusion].
    Kühnl P; Löliger C; Laufs R
    Chirurg; 1994 Dec; 65(12):1071-4. PubMed ID: 7851137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her own words: Kristin Turner's safety crusade.
    Bersch C
    MLO Med Lab Obs; 2005 Feb; 37(2):30-1. PubMed ID: 15762351
    [No Abstract]   [Full Text] [Related]  

  • 16. Current issues in blood component therapy: transmission of infectious diseases.
    Menitove JE
    Oncology (Williston Park); 1987 Jun; 1(4):21-30. PubMed ID: 2856350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV/AIDS and hepatitis C transmission by blood transfusion: zero risk does not exist].
    Rev Infirm; 2002 Apr; (80):11. PubMed ID: 12046116
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV, HBV and HCV: new developments related to transfusion safety.
    Busch MP
    Vox Sang; 2000; 78 Suppl 2():253-6. PubMed ID: 10938963
    [No Abstract]   [Full Text] [Related]  

  • 20. [Maternal-fetal transmission of HCV. Role of HIV as a risk factor].
    Catalano D; Pollio F; Ercolano S; Ascione L; Desantis B; Russo C
    Minerva Ginecol; 1999 Apr; 51(4):117-9. PubMed ID: 10379146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.